The revision of the Declaration of Helsinki: past, present and future.

The World Medical Association's Declaration of Helsinki was first adopted in 1964. In its 40-year lifetime the Declaration has been revised five times and has risen to a position of prominence as a guiding statement of ethical principles for doctors involved in medical research. The most recent revision, however, has resulted in considerable controversy, particularly in the area of the ethical requirements surrounding placebo-controlled trials and the question of responsibilities to research participants at the end of a study. This review considers the past versions of the Declaration of Helsinki and asks the question: How exactly has the text of the Declaration changed throughout its lifetime? Regarding the present form of the Declaration of Helsinki we ask: What are the major changes in the most recent revision and what are the controversies surrounding them? Finally, building on the detailed review of the past and present versions of the Declaration of Helsinki, we give consideration to some of the possible future trajectories for the Declaration in the light of its history and standing in the world of the ethics of medical research.

[1]  E. Emanuel,et al.  The ethics of placebo-controlled trials--a middle ground. , 2001, The New England journal of medicine.

[2]  R. Levine,et al.  The need to revise the Declaration of Helsinki. , 1999, The New England journal of medicine.

[3]  P. Appelbaum,et al.  The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia. , 2003, The American journal of psychiatry.

[4]  Tony Delamothe,et al.  Open access publishing takes off , 2004, BMJ : British Medical Journal.

[5]  K. McAdam,et al.  The ethics of research related to healthcare in developing countries , 2003 .

[6]  S. Glasser,et al.  The placebo effect in cardiovascular disease. , 1996, American heart journal.

[7]  S Holm,et al.  Principles of Biomedical Ethics, 5th edn. , 2002 .

[8]  R. Veatch.  The foundations of bioethics. , 1999, Bioethics.

[9]  P. Riis.  Perspectives on the Fifth Revision of the Declaration of Helsinki. , 2000, JAMA.

[10]  D. Kupfer,et al.  National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. , 2002, Archives of general psychiatry.

[11]  E. Emanuel,et al.  The ethics of placebo-controlled trials--a middle ground. , 2001 .

[12]  D. Carnall,et al.  Careers advice for doctors , 1996, BMJ.

[13]  H. Frankish.  WMA postpones decision to amend Declaration of Helsinki , 2003, The Lancet.

[14]  K. Vanhoozer.  Is There a Meaning in This Text?: The Bible, the Reader, and the Morality of Literary Knowledge , 1998 .

[15]  D. Southgate.  The ethics of peer review , 1992, British Journal of Nutrition.

[16]  T. Beauchamp,et al.  Principles of biomedical ethics , 1991 .

[17]  A. Flanagin.  Who wrote the Declaration of Helsinki? , 1997, JAMA.

[18]  K. Rothman,et al.  Update on unethical use of placebos in randomised trials. , 2003, Bioethics.

[19]  S. Ellenberg,et al.  Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases , 2000, Annals of Internal Medicine.

[20]  M. Hagberg.  Editorial , 2004 .

[21]  C. Lewis.  Till we have faces : a myth retold , 1979 .

[22]  M. Weber.  The ethics of using placebo in hypertension clinical trials. , 1999, Journal of hypertension.

[23]  C. Weijer,et al.  Bioethics for clinicians: 10. Research ethics. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[24]  S. Eckstein.  Ethical principles for medical research involving human subjects. , 2001, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[25]  P. Singer,et al.  Bioethics for clinicians. , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[26]  The World Medical Association. , 1962 .

[27]  Rickham Pp.  Human Experimentation: Code of Ethics of the World Medical Association (Declaration of Helsinki). , 1964, Canadian Medical Association journal.

[28]  S S Ellenberg,et al.  Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues , 2000, Annals of Internal Medicine.

[29]  H. Sass.  Reichsrundschreiben 1931: pre-Nuremberg German regulations concerning new therapy and human experimentation. , 1983, The Journal of medicine and philosophy.

[30]  G. Madison.  Hermeneutics : Gadamer and Ricoeur , 2003 .

[31]  K J Rothman,et al.  The continuing unethical use of placebo controls. , 1994, The New England journal of medicine.

[32]  K J Rothman,et al.  Placebo mania , 1996, BMJ.

[33]  W. Brown,et al.  The placebo effect. , 1998, Scientific American.

[34]  H. Möller,et al.  Placebo-controlled studies in depression: necessary, ethical and feasible , 2003, European Archives of Psychiatry and Clinical Neuroscience.

[35]  Nancy J. Dickey,et al.  Is the Use of Placebo Controls Ethically Permissible in Clinical Trials of Agents Intended to Reduce Fractures in Osteoporosis? , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  R. Levine,et al.  Some Recent Developments in the International Guidelines on the Ethics of Research Involving Human Subjects a , 2000, Annals of the New York Academy of Sciences.

[37]  P. P. Rickham.  HUMAN EXPERIMENTATION. CODE OF ETHICS OF THE WORLD MEDICAL ASSOCIATION. DECLARATION OF HELSINKI. , 1964, British medical journal.

[38]  Rheumatic Heart Disease in Dewsbury , 1937, British medical journal.

[39]  B. Gandevia,et al.  DECLARATION OF HELSINKI , 1964, Definitions.

[40]  J. Reginster,et al.  The Use of Placebo-Controlled and Non-inferiority Trials for the Evaluation of New Drugs in the Treatment of Postmenopausal Osteoporosis , 2002, Osteoporosis International.

[41]  R. Carlson,et al.  One standard, not two , 2003, The Lancet.